Blue Lipo Lab PPC for the body. Purple Lipo Lab V-Line for the face. Kabelline for a deoxycholic-acid-led option. Compare what is inside, what the evidence actually supports, when results can be judged, how to plan a course and what aftercare matters.
The direct answer: which fat dissolver is best?
There is no honest universal winner among Lipo Lab PPC, Lipo Lab V-Line and Kabelline. The right choice starts with the treatment area and the verified current formula, because these are not three interchangeable boxes of the same liquid.
For a small, pinchable body-fat pocket, the blue Lipo Lab PPC Solution is the product-aligned choice. It is the body version and publicly lists phosphatidylcholine (PPC) plus sodium deoxycholate, with L-carnitine and sodium hyaluronate. The direct fat-cell-disrupting action in this type of mixture is associated mainly with the deoxycholate component.
For a small facial contouring concern, the purple Lipo Lab V-Line is the face version. Its public product guide lists a different, multi-ingredient blend based on L-carnitine, amino acids, vitamins, plant extracts, metabolic cofactors and hyaluronate. It should not be presented as a small box of blue PPC. It has a face-specific product position, but the exact current V-Line formula has less direct clinical evidence for fat-cell destruction than deoxycholic acid.
For a buyer who specifically wants a deoxycholic-acid-led product, Kabelline has the clearest single active named on its manufacturer page. Deoxycholic acid is also the ingredient class with the strongest published human evidence for reducing fat under the chin. That does not prove Kabelline itself performs like prescription Kybella, because concentration, excipients, quality controls, labelling and clinical evidence can differ.
The practical answer is therefore:
- Body concern: start by comparing the blue Lipo Lab PPC with the size and nature of the body-fat pocket.
- Face or jawline concern: compare the purple V-Line's face-specific positioning with Kabelline's more direct deoxycholic-acid mechanism.
- Evidence-first decision: deoxycholic acid has the strongest ingredient-class evidence, but none of these three brands has a reliable head-to-head trial proving it is “the strongest.”
- U.S. regulatory decision: the FDA names Lipo Lab and Kabelline among unapproved fat-dissolving injections; Kybella is the only FDA-approved injectable for adult submental fat, and only for that area. Rules differ by country, so local status must be checked before purchase or treatment.
Lipo Lab PPC vs V-Line vs Kabelline at a glance
| Decision point | Lipo Lab PPC — blue box | Lipo Lab V-Line — purple box | Kabelline |
|---|---|---|---|
| Product position | Body version | Face version | Localized contouring product built around deoxycholic acid |
| Best-matched concern | Small, localized body pockets such as abdomen, flanks, thighs, hips, upper arms or bra-line fat | Lower-face fullness, jawline, jowls or double-chin concerns when a face-specific formula is preferred | A small localized pocket, commonly considered for under-chin or other limited areas where permitted and appropriate |
| Publicly documented formula | PPC, sodium deoxycholate, L-carnitine, sodium hyaluronate | L-carnitine, amino acids, vitamins, plant extracts, metabolic cofactors and hyaluronate | Manufacturer page verifies deoxycholic acid; verify the complete current label before relying on reseller ingredient lists |
| Most relevant mechanism | Deoxycholate disrupts cell membranes; PPC changes the formulation and may moderate/emulsify lipid material | Metabolic-cofactor and skin-support rationale; the exact formula's direct adipocytolytic effect is not well established in published trials | Deoxycholic acid physically disrupts fat-cell membranes and triggers an inflammatory clean-up response |
| Strength of evidence | Mechanism and PCDC mixtures have published evidence; exact Lipo Lab brand outcomes are not established by a head-to-head trial | Lowest direct fat-dissolving evidence of the three reviewed formulas; no peer-reviewed trial of the exact current formula was identified | Strongest ingredient-class human evidence, but that evidence is mainly for pharmaceutical deoxycholic acid under the chin, not Kabelline-specific performance |
| Course information | Public product guide: 2–5 sessions, 10–15 days apart | Public product guide: 3–5 sessions, 3–4 weeks apart | Current manufacturer page does not publish a validated treatment course |
| Current pack | 10 × 10 mL vials | 5 × 10 mL vials | 5 × 8 mL vials |
| Main limitation | More product volume does not make it suitable for weight loss or large-volume reshaping | Face-specific positioning is clearer than the clinical evidence for the exact blend | It must not be treated as generic Kybella or assigned Kybella's results and schedule |
The course figures above are public product-guide ranges, not patient-specific instructions. A pack size is inventory information, not a dose, and a shorter listed interval is not automatically a better or faster course.
Lipo Lab PPC
Lipo Lab V-Line
Kabelline
What is different about each product?
Blue Lipo Lab PPC: the body-oriented PCDC option
The blue box is the Lipo Lab product designed for body contouring. Its public formula contains PPC and sodium deoxycholate, the pairing often called PCDC, alongside L-carnitine and sodium hyaluronate.
This distinction matters because a PCDC product is not simply “mobilising” stored fat. Laboratory and tissue research found that sodium deoxycholate behaves as a detergent and disrupts cell membranes. The response also creates local inflammation, which explains why swelling, tenderness and firmness can appear before a visible contour change. PPC is part of the formulation, but research comparing the components suggests that deoxycholate is the principal membrane-disrupting agent rather than PPC acting alone.
Blue PPC makes the most sense when the objective is a modest change in a defined body pocket rather than general weight loss. It is a weak match for visceral abdominal fat, widespread obesity, major skin laxity or a client expecting liposuction-level change from a box of vials.
View the blue Lipo Lab PPC body product on MJS
Purple Lipo Lab V-Line: the face-oriented formula
The purple box is the facial version. It is positioned for the double chin, jawline, jowls and other lower-face contour concerns, and the reviewed public product guide lists a long, different formula that includes L-carnitine, amino acids, B vitamins, vitamin C derivatives, plant extracts, organic-acid cofactors, Coenzyme A and hyaluronate.
Those ingredients have understandable biological roles. L-carnitine helps transport fatty acids into mitochondria during normal energy metabolism; amino acids, vitamins and Coenzyme A participate in cellular metabolic pathways; hyaluronate supports hydration; and plant-derived ingredients are generally positioned for microcirculation or skin support. However, a plausible role in metabolism or skin condition is not the same as proof that the injected finished product destroys a predictable amount of facial fat.
That is the honest advantage-and-limit statement for V-Line: it is clearly the face-specific Lipo Lab product, and its multi-ingredient formula may suit a buyer who values facial contouring plus skin-support positioning, but its exact current formula has less direct clinical evidence than a deoxycholic-acid product. It should be sold on correct product identity and realistic expectations, not described as the same PPC/deoxycholate mechanism as the blue box unless the current label explicitly confirms that formulation.
View the purple Lipo Lab V-Line face product on MJS
Kabelline: the deoxycholic-acid-led option
Kabelline's manufacturer page gives a simpler public description: deoxycholic acid, supplied as five 8 mL vials. Some reseller pages add L-carnitine, peptides or other supporting ingredients, but those additions should not be treated as verified across every current version unless they appear on the box, label or instructions supplied with the actual product.
Deoxycholic acid has the clearest direct mechanism in this comparison. It disrupts adipocyte membranes, after which an inflammatory response and tissue clean-up occur. Randomised trials and meta-analyses of pharmaceutical deoxycholic acid show that the ingredient can reduce submental fat, but they also consistently report local swelling, pain, bruising, numbness, redness, firmness and nodules.
The evidence advantage is ingredient-level, not a blank cheque for Kabelline. There is no sound basis for saying that Kabelline is identical to Kybella, has the same concentration, should use the same treatment plan or will produce the same result. Kabelline is the most direct choice of these three when the buyer wants a deoxycholic-acid-led product, but the exact current formula and local professional-use status still need verification.
Which ingredients actually affect fat cells?
Deoxycholic acid and sodium deoxycholate: the direct membrane-disrupting mechanism
Deoxycholic acid is a bile-acid-related detergent. Research shows that deoxycholate can disrupt cell membranes and reduce fat-cell viability. Fat tissue may be especially vulnerable because it has less protein available to neutralise that detergent action, but the effect is not magically selective in every tissue. This is why anatomy, product placement and professional technique affect both outcome and complication risk.
The visible result is not immediate “melting.” First comes local cell injury and inflammation; then macrophages and tissue-remodelling processes clear debris over time. Swelling can temporarily make the area look larger, and a firm or lumpy feel can occur while the tissue settles.
Phosphatidylcholine: part of the PCDC system, but not the proven star by itself
PPC is a naturally occurring phospholipid and historically received much of the credit for “fat dissolving.” Experimental research, however, found similar membrane disruption from the complete PPC/deoxycholate formula and isolated sodium deoxycholate. Other work found that PPC alone did not cause the same loss of adipocyte viability and may partly buffer deoxycholate's detergent effect.
For the blue Lipo Lab product, this means the mechanism is credible, but the simple marketing statement “PPC dissolves fat” is incomplete. The deoxycholate component is central to the direct cell-disrupting effect.
L-carnitine, vitamins, amino acids and hyaluronate: support is not the same as cell destruction
L-carnitine has a real role in fatty-acid transport inside normal metabolism, but that fact alone does not establish how much localized fat an injectable finished product will remove. Vitamins, amino acids and Coenzyme A support cellular processes, while hyaluronate can support hydration and tissue feel. These ingredients may help explain V-Line's facial and skin-support positioning, yet they do not have the same direct evidence for adipocyte membrane destruction as deoxycholic acid.
This is why counting ingredients is a poor way to choose a fat dissolver. A longer formula is not automatically stronger, and a more inflammatory experience is not proof of a better result.
What results are realistic, and when can they be judged?
Fat-dissolving injections are best understood as gradual contour-refinement treatments for small localized deposits. They are not weight-loss injections, they do not remove visceral fat, and they do not reliably tighten major loose skin. Liposuction can create a larger single-procedure volume change; injection lipolysis usually produces a subtler change over a course.
A practical results timeline
| Time after treatment | What the client may notice | What it means for decision-making |
|---|---|---|
| First several days | Swelling, redness, tenderness, bruising, stinging, numbness or firmness | The area may look fuller. Pain or swelling does not prove efficacy, and lack of dramatic swelling does not prove failure. |
| About 1–2 weeks | Swelling may be decreasing while firmness, numbness or small lumps can remain | It is often still too early to judge contour or compare photographs fairly. |
| Around 4–8 weeks | The treated area is usually more assessable; professional guidance for deoxycholic-acid injection lipolysis commonly places visible change in this window | Compare standardised photographs, measurements and the remaining pinchable fat before deciding on another session. |
| After the final treatment | Results continue to develop; the American Academy of Dermatology says the full effect of approved under-chin injections is often seen about 3–4 months after the last treatment | This timing describes an evidence-based under-chin treatment category, not a guaranteed Lipo Lab or Kabelline result. |
One session may create a subtle change in a very small pocket, but it should not be promised. Conversely, repeatedly treating before swelling has settled can make the course look ineffective because every comparison is being made during inflammation.
What treatment course gives the best chance of an assessable result?
The best course is not the one that uses the most vials or the shortest interval. It is the one that matches the correct formula to a defined area, allows recovery, measures the response and stops when additional treatment is no longer justified.
Published product-guide ranges
| Product | Public guide range | How to interpret it responsibly |
|---|---|---|
| Blue Lipo Lab PPC | 2–5 sessions, commonly listed 10–15 days apart | This is manufacturer/distributor guidance for the product, not a universal medical standard. A practitioner should not repeat treatment into tissue that remains significantly swollen, hot, tender or difficult to assess. |
| Purple Lipo Lab V-Line | 3–5 sessions, commonly listed 3–4 weeks apart | The longer facial reassessment window is more compatible with judging a small contour change, but the exact current label and the client's recovery still take priority. |
| Kabelline | No validated course is stated on the current JDBIO product page reviewed for this article | Prescription deoxycholic-acid evidence under the chin uses multiple treatments separated by at least one month. That context supports staged reassessment, but the Kybella schedule must not be copied to Kabelline. |
A five-step course that avoids treating the box as the protocol
- Define the real target. Confirm that the concern is a small, pinchable subcutaneous-fat pocket. A protruding abdomen can be visceral fat; lower-face width can come from bone, muscle, glands or loose skin; and post-liposuction irregularity can contain scar tissue. None of those problems is solved simply by choosing a stronger dissolver.
- Verify the exact product before planning the course. Match the complete name, box colour, vial volume, ingredient label, lot, expiry, seal and authenticity information. MEDIHUB's Lipo Lab site directs buyers to use the QR code on the box. Public product pages can describe different versions, so the supplied label outranks an old web listing.
- Create a baseline before the first session. Use the same pose, camera distance, lighting and body weight for photographs; add a simple circumference or skin-fold measurement when appropriate. Without a baseline, normal swelling and day-to-day variation can be mistaken for either success or failure.
- Reassess only after the reaction is settling. Record swelling, pain, numbness, firmness and any asymmetry. Compare the contour when the area is calm enough to evaluate, not simply when the calendar reaches the earliest marketed interval.
- Continue only for a reason. Another session makes sense only when there is remaining treatable fat, the previous response was acceptable and the expected incremental benefit still justifies the downtime and risk. Stop at the goal, at a plateau, or when adverse effects or anatomy point to a different treatment.
This staged approach gives a better chance of seeing whether the product is working and prevents a ten-vial box from quietly becoming a ten-vial patient plan.
Aftercare: what to do after fat-dissolving injections
The exact product instructions and the treating professional's written aftercare should always take priority. Protocols differ, especially on massage, so aftercare should not be copied from a different brand.
During the first 24–48 hours
Keep the injection sites clean and avoid unnecessary rubbing, pressing or massage. A clean, wrapped cool compress can be used gently for comfort if the treating professional allows it; ice should not be applied directly to the skin. Avoid intense heat such as saunas, steam rooms and very hot baths while swelling and redness are active. Strenuous exercise and alcohol can worsen bruising or discomfort, so many clinical aftercare protocols advise avoiding them for the first day or two.
Use only pain relief that is compatible with the client's medical history and has been approved by the treating professional. A blog should never tell someone to stop prescribed anticoagulants or begin anti-inflammatory medication on their own.
Over the next several days
Swelling, tenderness, bruising, numbness and areas of firmness should trend toward improvement rather than become progressively more severe. Loose clothing can reduce pressure over a body area. For a facial area, planning treatment away from an important event is sensible because visible swelling can last longer than expected in some people.
Do not judge the result by how painful the treatment felt, and do not repeatedly press a firm area to “break it down.” Massage advice genuinely varies between products and clinics; the safest general rule is no massage unless the instructions for that exact treatment explicitly require it.
Before another session
The skin should be intact, any bruising should be resolving, and swelling, warmth, pain and firmness should be sufficiently settled for the contour to be assessed. The review should compare the baseline with the same photographs and measurements, then decide whether the remaining concern is still treatable fat or something the injection cannot correct.
Normal recovery or a red flag?
| More commonly expected and usually temporary | Contact the treating clinic promptly | Seek urgent medical care |
|---|---|---|
| Local swelling, bruising, redness, tenderness, stinging, numbness, firmness or small lumps that gradually improve | Pain or swelling that is worsening rather than settling; spreading redness or heat; drainage; fever; painful knots that persist or enlarge; a pale, grey, mottled, blistered or open skin area | Difficulty breathing or swallowing, rapidly progressive facial or neck swelling, collapse, or signs of a severe allergic reaction |
After treatment near the jawline, a new uneven smile or facial weakness also requires prompt clinical assessment because deoxycholic-acid injection lipolysis has a recognised nerve-injury risk. These warning signs are not reasons to panic about every bruise; they are the boundary between monitoring a predictable local reaction and getting the area checked early.
Who is a good match, and who should choose another route?
A better candidate is near a stable weight, has a small localized pocket of pinchable fat, understands that the change will be gradual and modest, can accept temporary swelling, and is willing to complete follow-up rather than treating the product as a one-off impulse purchase.
The match is poor when the main goal is overall weight loss, the abdominal concern is mainly visceral fat, the desired change is large, or loose skin is the dominant problem. Facial fullness also needs an anatomical assessment because masseter muscle, bone structure, salivary glands and skin laxity can all create width or heaviness without being a removable fat pocket.
Pregnancy or breastfeeding, active infection or damaged skin in the treatment area, important allergies, bleeding disorders or medicines that affect bleeding, previous swallowing difficulty, and relevant nerve or surgical history all require product-specific screening before treatment. The purpose of screening is not a generic disclaimer: each issue can change whether an injectable treatment, a different product or no treatment is the safer and more useful decision.
For a large volume or a dramatic single-procedure result, liposuction may be the more realistic comparison. For skin laxity, a skin-tightening or lifting strategy may address the actual concern better. For general weight management, nutrition, activity and evidence-based medical care work at a different level than a localized contouring injection.
Compact product specifications
| Product | Box colour / role | Public formula summary | Pack |
|---|---|---|---|
| Lipo Lab PPC Solution | Blue / body | Phosphatidylcholine, sodium deoxycholate, L-carnitine, sodium hyaluronate | 10 × 10 mL vials |
| Lipo Lab V-Line | Purple / face | L-carnitine, amino acids, vitamins, plant extracts, metabolic cofactors, hyaluronate; verify current label because public pages vary | 5 × 10 mL vials |
| Kabelline | White and red / localized contouring | Deoxycholic acid verified by the current manufacturer page; verify the complete supplied formula | 5 × 8 mL vials |
These specifications identify the products. They do not state a dose, number of injection points, depth or self-treatment method.
Frequently asked questions
Is Lipo Lab PPC stronger than Kabelline?
No reliable head-to-head clinical trial answers that question. Blue Lipo Lab combines PPC with sodium deoxycholate, while Kabelline's manufacturer page identifies deoxycholic acid. Deoxycholic acid has the stronger ingredient-class human evidence, but pain, swelling or ingredient count cannot establish which brand will produce a larger result.
Which is better for the face: V-Line or Kabelline?
Purple V-Line is explicitly the face version and uses a broad metabolic and skin-support formula. Kabelline gives the clearer deoxycholic-acid mechanism. The choice depends on whether the priority is face-specific product positioning or a directly adipocytolytic active, together with the exact current label, local status, anatomy and tolerance for inflammation. Neither should be selected for a facial concern that is not actually caused by subcutaneous fat.
Which is better for the stomach or body?
Among these three, blue Lipo Lab PPC is the body-oriented product. It may suit a small, localized subcutaneous pocket, but it will not treat visceral abdominal fat or create the volume reduction of liposuction.
How many sessions are needed?
The public Lipo Lab guide lists 2–5 sessions for blue PPC and 3–5 for purple V-Line. The current Kabelline manufacturer page does not provide a validated course. The useful stopping point depends on objective change, remaining treatable fat, complete enough recovery and whether the next incremental result justifies another treatment—not on finishing the box.
How long does it take to see a result?
Do not judge the first swollen week. Professional sources place more assessable injection-lipolysis change around 6–8 weeks, while the American Academy of Dermatology notes that the full effect of approved under-chin injections can take about 3–4 months after the last treatment. Exact Lipo Lab and Kabelline timelines are not proven to be identical.
Does more swelling mean the product is working better?
No. Swelling is an inflammatory response, not a calibrated measure of fat reduction. A more painful or swollen course can still produce a modest result, and a milder reaction does not automatically mean failure.
Should the treated area be massaged?
Not by default. Published and clinic protocols conflict between products. Follow the written instruction for the exact formula and treatment; aggressive rubbing of an inflamed area can worsen irritation and make complications harder to interpret.
Is Kabelline the same as Kybella?
No. Both are described in relation to deoxycholic acid, but Kybella is a specific prescription product with an FDA-approved label and clinical-trial programme for adult submental fat. That approval, concentration, schedule and outcome data cannot be transferred to Kabelline.
Can these products be self-injected?
They should not be treated as DIY products. Correct diagnosis of the fat pocket, facial and body anatomy, sterility, product identity, placement and complication recognition all affect the result. The FDA specifically advises consumers not to buy unapproved fat-dissolving products online and inject themselves.
How to choose the product before ordering
Start with the treatment area, then compare the active system and evidence rather than the price per vial. Ask for the current product name, front and back label, ingredient list, lot, expiry, seal, pack count and authenticity information. For Lipo Lab, compare the blue body box with the purple face box and use the MEDIHUB QR-verification route where available. For Kabelline, confirm that the supplied label matches the deoxycholic-acid product and do not assume every reseller's expanded ingredient list applies to the current batch.
Compare all MJS lipolysis products or contact MJS for current product and pack information. MJS supplies products through its sales channel; it is not the manufacturer of these brands and does not replace the qualified professional who determines patient suitability and treatment planning.
For a deeper two-product explanation, read Lipo Lab Blue vs Purple: ingredients, results, course and aftercare.
Evidence and product sources
- MEDIHUB official Lipo Lab site and QR authenticity prompt
- Public Lipo Lab PPC product guide
- Public Lipo Lab V-Line product guide
- JDBIO Kabelline product page
- FDA: unapproved fat-dissolving injections and the Kybella distinction
- DailyMed: Kybella prescribing information
- Rotunda et al.: detergent effects of sodium deoxycholate in a PPC formulation
- 2021 systematic review and meta-analysis of injectable deoxycholic acid
- 2023 systematic review, adverse effects and potential industry bias
- American Academy of Dermatology: results, recovery and candidate overview
- American Society of Plastic Surgeons: injection-lipolysis timeline and risks
This article is an evidence-led product comparison, not an injection manual or personalised medical advice. It intentionally does not provide injection sites, depth, needle selection, dilution or per-site dosing. Product labels, permitted uses and professional requirements vary by market and can change.
